Altimmune, Inc. (ALT)
4.16
0.00 (0.00%)
USD |
NASDAQ |
Mar 03, 16:00
4.155
0.00 (0.00%)
After-Hours: 20:00
Altimmune Research and Development Expense (Annual) : 81.99M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Eli Lilly & Co. | 13.34B |
| Viking Therapeutics, Inc. | 344.96M |
| CorMedix, Inc. | 3.942M |
| Actinium Pharmaceuticals, Inc. | 29.88M |